Oncostellae is a biopharmaceutical company built on its founders’ proven track record of creating innovative drug discovery programs, and transforming new chemical entities (NCEs) into clinical candidates, and licensing them to multinational pharmaceutical companies.
Business areas:
Pharmaceuticals. Small molecule drugs (NCEs) for oral administration.
Business lines:
Clinical candidates for out-licensing after clinical phases I/IIa.
Outlicensing.